|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 441.10 INR | +0.35% |
|
-4.94% | -4.24% |
| 07/05 | Aarti Drugs Consolidated Net Profit Jumps in Fiscal Q4 | MT |
| 07/05 | Aarti Drugs Limited, Q4 2025 Earnings Call, May 07, 2025 |
| Capitalization | 4.06TCr 47Cr 41Cr 38Cr 35Cr 64Cr 72Cr 453.02Cr 173.37Cr 1.86TCr 175.69Cr 171.95Cr 6.83TCr | P/E ratio 2025 |
18.5x | P/E ratio 2026 * | 19x |
|---|---|---|---|---|---|
| Enterprise value | 4.06TCr 47Cr 41Cr 38Cr 35Cr 64Cr 72Cr 453.02Cr 173.37Cr 1.86TCr 175.69Cr 171.95Cr 6.83TCr | EV / Sales 2025 |
1.31x | EV / Sales 2026 * | 1.51x |
| Free-Float |
38.16% | Yield 2025 * |
0.18% | Yield 2026 * | 1.31% |
More valuation ratios
* Estimated data
More news
Last Transcript: Aarti Drugs Limited
| Aarti Drugs : Loss of Share Certificates | 28/22/28 | PU |
| Aarti Drugs : Newspaper Advertisements | 10/22/10 | PU |
| 1 day | +0.35% | ||
| 1 week | -4.94% | ||
| Current month | -0.87% | ||
| 1 month | -6.03% | ||
| 3 months | +26.81% | ||
| 6 months | +3.15% | ||
| Current year | -4.24% |
| 1 week | 431.35 |  | 466.75 |
| 1 month | 431.35 | | 494 |
| Current year | 312.5 | | 494.9 |
| 1 year | 312.5 | | 634.9 |
| 3 years | 310.8 | | 645 |
| 5 years | 266.01 | | 1,025 |
| 10 years | 104.82 | | 1,025 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 77 | 01/06/2007 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 42 | 06/07/2012 |
Rushikesh Deole
CMP | Compliance Officer | - | 23/04/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 77 | 01/04/2014 | |
| Director/Board Member | 61 | 01/06/2007 | |
| Chairman | 78 | - |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0% | 89 M€ | -4.88% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.35% | -4.94% | -15.36% | +14.26% | 47Cr | ||
| -2.84% | -6.91% | -13.91% | +162.20% | 68TCr | ||
| -0.62% | -4.65% | +1.36% | -11.61% | 36TCr | ||
| -2.58% | -7.83% | -52.12% | +25.00% | 33TCr | ||
| -0.10% | -3.02% | +7.65% | +34.00% | 33TCr | ||
| -0.27% | -3.86% | +3.72% | -14.84% | 25TCr | ||
| -0.34% | -2.34% | +0.59% | +19.15% | 23TCr | ||
| -1.52% | -5.41% | -16.18% | +3.36% | 22TCr | ||
| -0.29% | -3.24% | -39.03% | -6.57% | 20TCr | ||
| -0.10% | -2.00% | -6.63% | +23.27% | 16TCr | ||
| Average | -0.22% | -4.25% | -12.99% | +24.82% | 27.52TCr | |
| Weighted average by Cap. | -0.17% | -4.71% | -12.63% | +47.16% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 2.3TCr 27Cr 23Cr 22Cr 20Cr 37Cr 41Cr 257.28Cr 98Cr 1.06TCr 100Cr 98Cr 3.88TCr | 2.69TCr 31Cr 27Cr 25Cr 23Cr 43Cr 48Cr 300.32Cr 114.93Cr 1.23TCr 116.47Cr 113.99Cr 4.53TCr |
| Net income | 141.2Cr 1.63Cr 1.41Cr 1.33Cr 1.21Cr 2.24Cr 2.52Cr 16Cr 6.04Cr 65Cr 6.12Cr 5.99Cr 237.78Cr | 212.1Cr 2.45Cr 2.12Cr 2Cr 1.82Cr 3.36Cr 3.79Cr 24Cr 9.07Cr 97Cr 9.19Cr 8.99Cr 357.18Cr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
1,064
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/25/20 | 441.10 ₹ | +0.35% | 17,776 |
| 19/25/19 | 439.55 ₹ | -1.61% | 15,333 |
| 18/25/18 | 446.75 ₹ | -0.90% | 7,036 |
| 17/25/17 | 450.80 ₹ | -2.48% | 15,500 |
| 16/25/16 | 462.25 ₹ | -0.38% | 18,096 |
Delayed Quote Bombay S.E., June 20, 2025 at 03:30 pm IST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
441.10INR
Average target price
461.00INR
Spread / Average Target
+4.51%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition